Elektrofi
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
25 Drydock Ave, Boston, Massachusetts, 0...Phone Number
(866) 610-2683Website
www.elektrofi.comRevenue
$14.8 MillionIndustry
About Elektrofi
Elektrofi, Inc. is a biotechnology and biopharmaceutical formulation technology company focused on transforming the administration and delivery of biologic medicines. The company develops advanced formulation technologies that enable biologic therapies to be administered subcutaneously rather than through conventional intravenous infusion methods. By concentrating on improving patient accessibility, convenience, and treatment flexibility, Elektrofi aims to redefine how complex biologic medicines are delivered across healthcare systems worldwide. The organization was established by a group of scientists, engineers, and biotechnology innovators with expertise spanning fluid mechanics, pharmaceutical science, protein formulation, microsystems engineering, and biologic drug delivery. The companys leadership and scientific foundation emerged from advanced academic and research environments, particularly from technology and engineering disciplines associated with scientific innovation in bioRead more
SIC Code 87,873NAICS Code 54,541Show moreElektrofi Org Chart
Compare Similar Companies to Elektrofi
Compare insights from companies similar to Elektrofi, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Elektrofi Tech Stack
A closer look at the technologies used by Elektrofi
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Elektrofi
Sign Up For FreeTo access detailed company insights
Elektrofi, Inc. is a biotechnology and biopharmaceutical formulation technology company focused on transforming the administration and delivery of biologic medicines. The company develops advanced formulation technologies that enable biologic therapies to be administered subcutaneously rather than through conventional intravenous infusion methods.... Read More